Blarcamesine for the Treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase Iib/iii Trial
Macfarlane, Stephen, Grimmer, Timo, Teo, Ken, O'Brien, Terence J, Woodward, Michael, Grunfeld, Jennifer, Mander, Alastair, Brodtmann, Amy, Brew, Bruce J., Morris, Philip, Short, Cathy, Kurrle, Susan, Lai, Rosalyn, Bharadwaj, Sneha, Drysdale, Peter, Sturm, Jonathan, Lewis, Simon J.G., Barton, David, Kalafatis, Chris, Sharif, Saif, Perry, Richard, Mannering, Nicholas, MacSweeney, J.Emer, Pearson, Evans, Craig, Krishna, Vivek, Thompson, Alex, Munisamy, Malathy, Bhatt, Neel, Asher, Aliya, Connell, Sandra, Lynch, Rutgers, Sterre Malou, Dautzenberg, Paul LJ, Prins, Niels, Oschmann, Patrick, Frölich, Lutz, Tacik, Pawel, Peters, Oliver, Wiltfang, Jens, Henri-Bhargava, Alexandre, Smith, Eric, Pasternak, Frank, Andrew, Chertkow, Howard, Ingram, Hsiung, Ging-Yuek Robin, Brittain, Rodney, Tartaglia, Carmela, Cohen, Sharon, Villa, Luca M, Gordon, Elizabeth, Jubault, Thomas, Guizard, Nicolas, Tucker, Amanda, Kaufmann, Walter E, Jin, Kun, Chezem, William R, Missling, Christopher U, Sabbagh, Marwan N
pdfen2025